Volume 75, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


The prevalence and risk factors for hepatitis delta virus (HDV) infection among Mongolian school children were assessed by detecting the antibody against HDV and HDV RNA, and through structured interviews. The study subjects consisted of 181 children with the past or ongoing hepatitis B virus infection who were investigated during the nationwide serosurvey conducted in 2004. The prevalence of antibody to HDV was 6.1%, with the proportion of 13.6% among hepatitis B surface antigen (HBsAg)-positive subjects, all of whom had HDV RNA. Multivariate logistic regression analyses showed that injections (> 11 times) (odds ratio [OR] = 8.31, 95% confidence interval [CI] = 1.28–54.07) and blood sampling (> 3 times) (OR = 5.34, 95% CI = 1.12–25.53) in health care settings, hospitalization (> 3 times) (OR = 6.20, 95% CI = 1.18–32.71), and cohabitating with patients with chronic hepatitis (OR = 4.57, 95% CI = 1.26–16.55) predicted the seropositivity for antibody to HDV. These results suggest that parenteral exposures in health care settings and household transmission are the main routes of HDV transmission among Mongolian children.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Rizzetto M, Hoyer B, Canese MG, Shih JWK, Purcell RH, Gerin JL, 1980. Delta agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci U S A 77 : 6124–6128. [Google Scholar]
  2. Lai MM, 1995. The molecular biology of hepatitis delta virus. Annu Rev Biochem 64 : 259–286. [Google Scholar]
  3. Huo TI, Wu JC, Wu SI, Chang AL, Lin SK, Pan CH, Huang YH, Chang FY, Lee SD, 2003. Changing seroepidemiology of hepatitis B, C, and D virus infections in high-risk populations. J Med Virol 72 : 41–45. [Google Scholar]
  4. Purcell RH, 1994. Hepatitis viruses: changing patterns of human disease. Proc Natl Acad Sci U S A 91 : 2401–2406. [Google Scholar]
  5. Rizzetto M, Ponzetto A, Forzani I, 1991. Epidemiology of hepatitis delta virus: overview. Prog Clin Biol Res 364 : 1–20. [Google Scholar]
  6. International Agency for Research on Cancer, 1994. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Hepatitis Viruses. Volume 59: 223–253. [Google Scholar]
  7. Farci P, 2003. Delta hepatitis: an update. J Hepatol 39 : S212–S219. [Google Scholar]
  8. Gerin JL, Casey JL, Purcell RH, 2001. Hepatitis delta virus. Knipe DM, Howley PM, eds. Fields Virology. Fourth edition. Philadelphia: Lippincott Williams and Wilkins, 2819–2829.
  9. Valla D, 2003. EASL international consensus conference on hepatitis B. J Hepatol 38 : 533–540. [Google Scholar]
  10. Hadziyannis SJ, 1997. Review: hepatitis delta. J Gastroenterol Hepatol 12 : 289–298. [Google Scholar]
  11. Abe K, Hayakawa E, Sminov AV, Rossina AL, Ding X, Huy TT, Sata T, Uchaikin VF, 2004. Molecular epidemiology of hepatitis B, C, D and E viruses among children in Moscow, Russia. J Clin Virol 30 : 57–61. [Google Scholar]
  12. Nymadava P, Anan’ev VA, Oiuunbileg Zh, Chernovetskii MA, 1988. The frequency of detecting antibodies to the delta antigen in virtually healthy HBsAg and anti-HBs carriers in Ulan-Bator. Vopr Virusol 33 : 246–247. [Google Scholar]
  13. Oyunsuren T, 2000. Viral hepatitis in Mongolia. Minophagen Med Rev 45 : 140–147. [Google Scholar]
  14. Inoue J, Takahashi M, Nishizawa T, Narantuya L, Sakuma M, Kagawa Y, Shimosegawa T, Okamoto H, 2005. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia. J Med Virol 76 : 333–340. [Google Scholar]
  15. Takahashi M, Nishizawa T, Gotanda Y, Tsuda F, Komatsu F, Kawabata T, Hasegawa K, Altankhuu M, Chimedregzen U, Narantuya L, Hoshino H, Hino K, Kagawa Y, Okamoto H, 2004. High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C, and D viruses among apparently healthy populations in Mongolia. Clin Diagn Lab Immunol 11 : 392–398. [Google Scholar]
  16. Davaalkham D, Ojima T, Nymadawa P, Uehara R, Watanabe M, Oki I, Nakamura Y, 2006. Prevalence and risk factors for hepatitis C virus infection in Mongolian children: findings from a nationwide survey. J Med Virol 78 : 466–472. [Google Scholar]
  17. Davaalkham D, Ojima T, Nymadawa P, Tsend N, Lkhagvasuren TS, Wiersma S, Uehara R, Watanabe M, Oki I, Nakamura Y, 2007. Seroepidemiology of hepatitis B virus infection in Mongolian children: a nationwide survey. Pediatr Int 49: (in press).
  18. Ebright JR, Altantsetseg T, Oyungerel R, 2003. Emerging infectious diseases in Mongolia. Emerg Infect Dis 9 : 1509–1515. [Google Scholar]
  19. Edstam JS, Dulmaa N, Nymadawa P, Rinchin A, Khulan J, Kimball AM, 2002. Comparison of hepatitis B vaccine coverage and effectiveness among urban and rural Mongolian 2-year-olds. Prev Med 34 : 207–214. [Google Scholar]
  20. Heller T, Hoofnagle JH, 2003. Denying the wolf access to sheep’s clothing. J Clin Invest 112 : 319–321. [Google Scholar]
  21. Taylor JM, 2006. Hepatitis delta virus. Virology 344 : 71–76. [Google Scholar]
  22. Huo TI, Wu JC, Lin RY, Sheng WY, Chang FY, Lee SD, 1997. Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors. J Gastroenterol Hepatol 12 : 747–751. [Google Scholar]
  23. Kao JH, Chen PJ, Lai MY, Chen DS, 2002. Hepatitis D virus genotypes in intravenous drug users in Taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes. J Clin Microbiol 40 : 3047–3049. [Google Scholar]
  24. Sagnelli E, Stroffolini T, Ascione A, Chiaramonte M, Craxi A, Giusti G, Piccinino F, 1997. Decrease in HDV endemicity in Italy. J Hepatol 26 : 20–24. [Google Scholar]
  25. Hadziyannis SJ, Dourakis SP, Papaioannou C, Alexopoulou A, Hadziyannis ES, Gioustozi A, 1993. Changing epidemiology and spreading modalities of hepatitis delta virus infection in Greece. Prog Clin Biol Res 382 : 259–266. [Google Scholar]
  26. Navascues CA, Rodriguez M, Sotorrio NG, Sala P, Linares A, Suarez A, Rodrigo L, 1995. Epidemiology of hepatitis D virus infection: changes in the last 14 years. Am J Gastroenterol 90 : 1981–1984. [Google Scholar]
  27. Sagnelli E, Felaco FM, Filippini P, Scolastico C, Rapicetta M, Stroffolini T, Piccinino F, 1997. Multiple hepatitis virus infections in chronic HBsAg carriers in Naples. Arch Virol 142 : 445–451. [Google Scholar]
  28. Craxi A, Tine F, Vinci M, Almasio P, Camma C, Garofalo G, Pagliaro L, 1991. Transmission of hepatitis B and hepatitis delta viruses in the households of chronic hepatitis B surface antigen carriers: a regression analysis of indicators of risk. Am J Epidemiol 134 : 641–650. [Google Scholar]
  29. Gaeta GB, Stroffolini T, Chiaramonte M, Ascione T, Stornaiuolo G, Lobello S, Sagnelli E, Brunetto MR, Rizzetto M, 2000. Chronic hepatitis D: A vanishing disease? An Italian multi-center study. Hepatology 32 : 824–827. [Google Scholar]
  30. Niro GA, Casey JL, Gravinese E, Garrubba M, Conoscitore P, Sagnelli E, Durazzo M, Caporaso N, Perri F, Leandro G, Facciorusso D, Rizzetto M, Andriulli A, 1999. Intrafamilial transmission of hepatitis delta virus: molecular evidence. J Hepatol 30 : 564–569. [Google Scholar]
  31. Liaw YF, Tsai SL, Sheen IS, Chao M, Yeh CT, Hsieh SY, Chu CM, 1998. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers. Am J Gastroenterol 93 : 354–359. [Google Scholar]

Data & Media loading...

  • Received : 26 Jan 2006
  • Accepted : 28 Mar 2006

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error